FEBRUARY 2026 NEWSLETTER
Highlights:
Thank you to the 200+ founders, operators and partners who joined us for Tau Ventures' annual event during the 44th J.P. Morgan Healthcare Conference! More here
We've kicked off fundraising for Fund III:
you can learn more by emailing us at [email protected]
Enterprise
Identity security automation across disconnected applications (Fund I | Co-investors: DTCP, Okta, Salesforce, Two Sigma, Ridge, Bowery)
Released a case study highlighting how Cerby is automating Colgate-Palmolive's identity workflows and reducing manual effort
Robotics platform for cloud kitchens (Fund I | Co-investors: Kleiner Perkins, Construct, Promus)
Featured in The Food Institute, with coverage on how Chef is helping address the food manufacturing labor crisis
Enabling high-throughput AI inference on edge devices (Fund II | Co-investors: Brave, Cota Capital, Essence VC)
Announced an inaugural industry partnership with the Responsible AI Collaborative to embed AI incident data into Trustible
Healthcare
Specialty-trained AI voice agents for patient calls (Fund II | Co-investors: Lightspeed, Felicis, First Round, Chemistry, Quiet, Liquid2)
Healthcare IT News detailed Annapolis Internal Medicine's decision to use Assort, and the "dramatic" impact it has had
Clinical intelligence platform empowering care teams to take the right action at the optimal time (Fund II | Co-investors: Flare, Eniac, Omega, Ziegler, DHVP)
Announced a new partnership with the American Association of Post-Acute Care Nursing (AAPACN) to enhance care coordination and provide resources to AAPACN members
Voice AI agents for clinical & administrative healthcare calls (Fund I | Co-investors: Kleiner, Coatue)
Case study released, showing how a top-10 pharma company achieved 400% ROI using Infinitus across patient access workflows
AI-enabled ambulatory surgery centers and operating system (Opty | Co-investors: FPV Ventures, McKesson Ventures, Black Opal, OSE, Rogue VC)
Announced a collaboration with NVIDIA to power OathOS, establishing the first multimodal, ambient clinical intelligence platform spanning outpatient care from referral to recovery
Real-time glucose insights to drive smarter weight loss (Fund I | Co-investors: GV, Cheyene, Samsung Next, Courtside, 1984)
CEO Sharam Fouladgar-Mercer joined The Tech Talks Daily to discuss why real-time metabolic insight is imperative
Ankit JainCEO & Co-founder of Infinitus
Voice AI agents for clinical & administrative healthcare calls (Fund I | Co-investors: Kleiner, Coatue)
1. Share your background, and the story behind starting your company
I grew up in the Bay Area after my family emigrated from India. My father was an entrepreneur, and I always saw myself as someone who would one day focus on building from the ground up just as he did. After grad school, I joined a search engine startup that ended up being acquired by Google, where I worked until 2013, when I left to launch my first startup as a founder.
I later returned to Google, where I founded its AI-focused venture capital fund, Gradient Ventures. I was there in 2018 when the company demoed its Duplex technology, which could automate phone calls. It was very clear almost right away that this incredible tech could have a far greater impact than making restaurant reservations, and in 2019 Infinitus was born.
2. What problems are you solving and how do you provide value to your customers?
In the
US, receiving healthcare depends on information changing hands. But that transfer of information is so much more complicated than it might at first appear – the data is siloed, hard to find, and often can only be communicated by phone call. We’re streamlining that transfer of information with AI, saving time and money in the process.
As an agentic healthcare communications platform, Infinitus uses AI to automate high stakes communication workflows between patients, providers, and payors. Some examples include answering patients’ questions about a diagnosis or medication regardless of time or day; performing health risk assessments to high-risk patient populations on behalf of Medicare plans; and calling payors to complete complex benefit verifications for life-saving specialty medications. These are all communication workflows that need to happen, but today, they’re either happening manually, inconsistently, or not happening at all (
).
3. What have you enjoyed, or what do you look forward to, about working with Tau Ventures?
The Tau Ventures team has built a network of incredible practitioners, mentors, and industry experts, and it has been enlightening to get to know them. Collaborating with Tau Ventures has been a good way for the entire Infinitus team to learn more about the areas of healthcare that we were less familiar with, and has also been a great source of talent as we continue to aggressively build out our team over the coming months.
Tau Ventures is an early stage VC fund investing in AI-first startups.
Visit us at www.tauventures.com.